المساهمون: College of Medicine, Dept. of Internal Medicine, S. J. Kim, D.-Y. Shin, J. S. Kim, D. H. Yoon, W. S. Lee, H. Lee, Y. R. Do, H. J. Kang, H. S. Eom, Y. H. Ko, S. H. Lee, H. Y. Yoo, M. Hong, C. Suh, W. S. Kim, Kim, Jin Seok

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Cyclophosphamide/administration & dosage, Cyclophosphamide/adverse effects, Disease-Free Survival, Doxorubicin/administration & dosage, Doxorubicin/adverse effects, Drug Administration Schedule, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Peripheral/pathology, Male, Middle Aged, Neoplasm Staging, PTEN Phosphohydrolase/biosynthesis, PTEN Phosphohydrolase/genetics, Prednisone/administration & dosage, Prednisone/adverse effects, TOR Serine-Threonine Kinases/antagonists & inhibitors, TOR Serine-Threonine Kinases/genetics, Treatment Outcome, Vincristine/administration & dosage, Vincristine/adverse effects

العلاقة: ANNALS OF ONCOLOGY; J00171; OAK-2016-07707; https://ir.ymlib.yonsei.ac.kr/handle/22282913/152779Test; T201605305; ANNALS OF ONCOLOGY, Vol.27(4) : 712-718, 2016

الإتاحة: https://doi.org/10.1093/annonc/mdv624Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152779Test

المساهمون: College of Medicine, Dept. of Internal Medicine, Sung-Jin Hong, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Ae-Young Her, Yong Hoon Kim, Yangsoo Jang, Myeong-Ki Hong, the IVUS-XPL Investigators, Ko, Young Guk, Kim, Byeong Keuk, Kim, Jung Sun, Shin, Dong Ho, Jang, Yang Soo, Choi, Dong Hoon, Hong, Myeong Ki

مصطلحات موضوعية: Aspirin/administration & dosage, Aspirin/adverse effects, Cardiovascular Agents/administration & dosage, Cardiovascular Agents/adverse effects, Coronary Thrombosis/etiology, Drug Administration Schedule, Drug Therapy, Combination, Drug-Eluting Stents, Everolimus/administration & dosage, Everolimus/adverse effects, Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Myocardial Infarction/etiology, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prosthesis Design, Republic of Korea, Risk Factors, Stroke/etiology, Ticlopidine/administration & dosage, Ticlopidine/adverse effects, Ticlopidine/analogs & derivatives, Time Factors, Treatment Outcome, coronary artery disease

وصف الملف: 1438~1446

العلاقة: JACC-CARDIOVASCULAR INTERVENTIONS; J01193; OAK-2016-03285; https://ir.ymlib.yonsei.ac.kr/handle/22282913/147133Test; http://www.sciencedirect.com/science/article/pii/S1936879816304897Test; T201602141; JACC-CARDIOVASCULAR INTERVENTIONS, Vol.9(14) : 1438-1446, 2016

الإتاحة: https://doi.org/10.1016/j.jcin.2016.04.036Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147133Test
http://www.sciencedirect.com/science/article/pii/S1936879816304897Test